Publication: Quantification of the antimalarial piperaquine in plasma
item.page.dc.date.issued
2008-05-01
item.page.dc.type
item.page.dc.identifier.issn
00359203
item.page.dc.identifier.doi
item.page.dc.identifier.other
2-s2.0-41749109301
item.page.dc.rights
Mahidol University
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol.102, No.5 (2008), 409-411
punsarn.item.page.citation
Joel Tarning, Niklas Lindegardh Quantification of the antimalarial piperaquine in plasma. Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol.102, No.5 (2008), 409-411. doi:10.1016/j.trstmh.2008.02.011 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/19332
Research Projects
Organizational Units
Authors
Journal Issue
relationships.isThesisOf
item.page.dc.title
Quantification of the antimalarial piperaquine in plasma
item.page.dc.contributor.author
item.page.dc.contributor.other
item.page.dc.description.abstract
Malaria is one of the most common parasitic diseases in the world, with up to three million deaths a year. Piperaquine is an antimalarial drug that was extensively used in China during the 1980s and has recently received renewed interest as a partner drug in artemisinin-based combination therapy. Despite extensive use, the first bioanalytical method was published in 2003. In total there are eight previously published methods for quantification of piperaquine in different biological matrices using HPLC with UV or tandem mass spectrometric detection. Five of these allow for quantification of piperaquine in plasma and are discussed in this paper. © 2008 Royal Society of Tropical Medicine and Hygiene.